D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
- 15 March 2005
- journal article
- clinical trial
- Published by Elsevier BV in Biological Psychiatry
- Vol. 57 (6), 577-585
- https://doi.org/10.1016/j.biopsych.2004.12.037
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Placebo-Controlled Trial ofd-Cycloserine Added to Conventional Neuroleptics, Olanzapine, or Risperidone in SchizophreniaAmerican Journal of Psychiatry, 2002
- Placebo-Controlled Trial of Glycine Added to Clozapine in SchizophreniaAmerican Journal of Psychiatry, 2000
- Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free SchizophrenicsNeuropsychopharmacology, 1997
- Depletion of Cerebral D-Serine in Non-Ketotic Hyperglycinemia: Possible Involvement of Glycine Cleavage System in Control of Endogenous D-SerineBiochemical and Biophysical Research Communications, 1997
- NMDA receptor function and human cognition: The effects of ketamine in healthy volunteersNeuropsychopharmacology, 1996
- Ketamine activates psychosis and alters limbic blood flow in schizophreniaNeuroReport, 1995
- Glycine Adjuvant Therapy to Conventional Neuroleptic Treatment in SchizophreniaClinical Neuropharmacology, 1989
- Excitatory Amino Acid Neurotransmission: NMDA Receptors and Hebb-Type Synaptic PlasticityAnnual Review of Neuroscience, 1988
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970